Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Abeona Therapeutics (ABEO) Non Operating Income: 2011-2025

Historic Non Operating Income for Abeona Therapeutics (ABEO) over the last 12 years, with Sep 2025 value amounting to $129,000.

  • Abeona Therapeutics' Non Operating Income fell 11.03% to $129,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 million, marking a year-over-year increase of 37.18%. This contributed to the annual value of $1.2 million for FY2024, which is 59.43% down from last year.
  • Per Abeona Therapeutics' latest filing, its Non Operating Income stood at $129,000 for Q3 2025, which was up 44.94% from $89,000 recorded in Q2 2025.
  • Abeona Therapeutics' 5-year Non Operating Income high stood at $2.2 million for Q2 2023, and its period low was -$19,000 during Q3 2022.
  • Over the past 3 years, Abeona Therapeutics' median Non Operating Income value was $162,000 (recorded in 2024), while the average stood at $408,727.
  • Per our database at Business Quant, Abeona Therapeutics' Non Operating Income surged by 37,016.67% in 2023 and then slumped by 89.89% in 2024.
  • Quarterly analysis of 4 years shows Abeona Therapeutics' Non Operating Income stood at $277,000 in 2022, then dropped by 22.74% to $214,000 in 2023, then spiked by 209.81% to $663,000 in 2024, then fell by 11.03% to $129,000 in 2025.
  • Its Non Operating Income was $129,000 in Q3 2025, compared to $89,000 in Q2 2025 and $141,000 in Q1 2025.